143 related articles for article (PubMed ID: 15389481)
1. The management of ductal carcinoma in situ in North America and Europe. Results of a survey.
Ceilley E; Jagsi R; Goldberg S; Kachnic L; Powell S; Taghian A
Cancer; 2004 Nov; 101(9):1958-67. PubMed ID: 15389481
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy for invasive breast cancer in North America and Europe: results of a survey.
Ceilley E; Jagsi R; Goldberg S; Grignon L; Kachnic L; Powell S; Taghian A
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):365-73. PubMed ID: 15667954
[TBL] [Abstract][Full Text] [Related]
3. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
Mokbel K
Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
[TBL] [Abstract][Full Text] [Related]
4. Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials.
Petrelli F; Barni S
Radiother Oncol; 2011 Aug; 100(2):195-9. PubMed ID: 21411161
[TBL] [Abstract][Full Text] [Related]
5. Contemporary treatment of ductal carcinoma in situ of the breast.
Mokbel K
Med Sci Monit; 2005 Mar; 11(3):RA86-93. PubMed ID: 15735580
[TBL] [Abstract][Full Text] [Related]
6. Survey of ASCO members on management of sentinel node micrometastases in breast cancer: variation in treatment recommendations according to specialty.
Wasif N; Ye X; Giuliano AE
Ann Surg Oncol; 2009 Sep; 16(9):2442-9. PubMed ID: 19506955
[TBL] [Abstract][Full Text] [Related]
7. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
[TBL] [Abstract][Full Text] [Related]
8. Results of a survey regarding irradiation of internal mammary chain in patients with breast cancer: practice is culture driven rather than evidence based.
Taghian A; Jagsi R; Makris A; Goldberg S; Ceilley E; Grignon L; Powell S
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):706-14. PubMed ID: 15465186
[TBL] [Abstract][Full Text] [Related]
9. Recent advances and current controversies in the management of DCIS of the breast.
Sakorafas GH; Farley DR; Peros G
Cancer Treat Rev; 2008 Oct; 34(6):483-97. PubMed ID: 18490111
[TBL] [Abstract][Full Text] [Related]
10. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
11. The management of ductal carcinoma in situ of the breast: a screened population-based analysis.
Rakovitch E; Pignol JP; Chartier C; Hanna W; Kahn H; Wong J; Mai V; Paszat L
Breast Cancer Res Treat; 2007 Mar; 101(3):335-47. PubMed ID: 16838110
[TBL] [Abstract][Full Text] [Related]
12. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
; ; Bijker N; Meijnen P; Peterse JL; Bogaerts J; Van Hoorebeeck I; Julien JP; Gennaro M; Rouanet P; Avril A; Fentiman IS; Bartelink H; Rutgers EJ
J Clin Oncol; 2006 Jul; 24(21):3381-7. PubMed ID: 16801628
[TBL] [Abstract][Full Text] [Related]
13. 1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer.
Pierce LJ; Moughan J; White J; Winchester DP; Owen J; Wilson JF
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):183-92. PubMed ID: 15850920
[TBL] [Abstract][Full Text] [Related]
14. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ.
Dunne C; Burke JP; Morrow M; Kell MR
J Clin Oncol; 2009 Apr; 27(10):1615-20. PubMed ID: 19255332
[TBL] [Abstract][Full Text] [Related]
15. Current management of DCIS: a review.
Patani N; Cutuli B; Mokbel K
Breast Cancer Res Treat; 2008 Sep; 111(1):1-10. PubMed ID: 17902049
[TBL] [Abstract][Full Text] [Related]
16. Impact of estrogen receptor expression and other clinicopathologic features on tamoxifen use in ductal carcinoma in situ.
Hird RB; Chang A; Cimmino V; Diehl K; Sabel M; Kleer C; Helvie M; Schott A; Young J; Hayes D; Newman L
Cancer; 2006 May; 106(10):2113-8. PubMed ID: 16596655
[TBL] [Abstract][Full Text] [Related]
17. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
18. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
19. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
Sanders ME; Schuyler PA; Dupont WD; Page DL
Cancer; 2005 Jun; 103(12):2481-4. PubMed ID: 15884091
[TBL] [Abstract][Full Text] [Related]
20. Ductal carcinoma in-situ: an update for clinical practice.
Patani N; Khaled Y; Al Reefy S; Mokbel K
Surg Oncol; 2011 Mar; 20(1):e23-31. PubMed ID: 21106367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
